Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis

AIDS. 2017 Jul 17;31(11):1647-1650. doi: 10.1097/QAD.0000000000001551.

Authors

Richard E Haaland¹, Amy Martin, Angela Holder, Jeffrey J Fountain, LaShonda Hall, Nicole A Pescatore, Sheila Heeke, Colleen F Kelley

Affiliation

¹ aDivision of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention bDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine cDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

No abstract available

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / urine*
Biomarkers / urine*
Cross-Sectional Studies
Emtricitabine / administration & dosage
Emtricitabine / urine*
HIV Infections / prevention & control*
Homosexuality, Male
Humans
Male
Pre-Exposure Prophylaxis / methods*
Tenofovir / administration & dosage
Tenofovir / urine*
Urinalysis

Substances

Antiviral Agents
Biomarkers
Tenofovir
Emtricitabine

Grants and funding